Business Wire

Alcon Launches AcrySof ReSTOR Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
Business Insider

Alcon Canada introduces AcrySof IQ Vivity, the only presbyopia-correcting intraocular lens with X-WAVE technology

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...
Nasdaq

Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Nasdaq

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
Business Wire

Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American ...
Healio

AcrySof ReStor provides good vision near and far, early results show

Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...
Yahoo UK & Ireland

Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...
Medscape

Monte Carlo Simulation of Expected Outcomes with the AcrySof

Background: To use a Monte Carlo simulation to predict postoperative results with the AcrySof ® Toric lens, evaluating the likelihood of over- or under-correction using various toric lens selection ...
PharmiWeb

Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

These results and additional data are being discussed in 11 sessions with world-renowned surgeons at the 41 st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), currently ...
Healio

FDA approves Alcon’s AcrySof IQ PanOptix trifocal IOL

Please provide your email address to receive an email when new articles are posted on . PanOptix, which is already available in more than 70 countries, has been shown to deliver a combination of near, ...
Yahoo Finance

Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS(TM) design for uncompromised distance vision and presbyopia correction

The unique optical design of the ACTIVEFOCUS (TM) toric IOL gives astigmatic cataract patients quality distance vision and an increased range of vision to potentially reduce dependence on glasses The ...